April 21, 2021 | Mia Scioscia Changes to State Price Transparency Reporting, Medicaid Laws Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
April 14, 2021 | integrichain The Current State of Drug Price Transparency Reporting What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk. Read More
March 11, 2021 | integrichain Advisory Market Update – March 2021 Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
February 16, 2021 | integrichain Advisory Market Update – February 2021 Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
January 28, 2021 | Mia Scioscia Five Steps to GTN Implementation Success Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices. Read More
December 10, 2020 | Mia Scioscia Gross to Net Roadmap to Launch A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product. Read More
October 26, 2020 | Mia Scioscia GTN Analytics: Improve Visibility and Predictability of Your Forecasting and Accrual Processes Data on Demand, GTN Reporting, Trends, and Metrics. Find out what's new in the latest ICyte Platform GTN Analytics release. Read More
October 15, 2020 | integrichain Advisory Market Update – October 2020 Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
September 17, 2020 | integrichain Advisory Market Update – September 2020 Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
August 11, 2020 | integrichain Advisory Market Update – August 2020 Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers. Read More
